Cargando…

PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME

Detalles Bibliográficos
Autores principales:	Ogbogu, Princess, Klion, Amy, Roufosse, Florence, Akuthota, Praveen, Khoury, Paneez, Shih, Vivian, Griffis, Dianne, Parikh, Himanshu, Chen, Ron, Fan, Ying, Mayer, Gaell, Jain, Priya, Katial, Rohit, Psallidas, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429737/ http://dx.doi.org/10.1097/01.HS9.0000975660.56238.59

Ejemplares similares

Clinical and Biological Markers in Hypereosinophilic Syndromes
por: Khoury, Paneez, et al.
Publicado: (2017)

COVID-19 infection in hypereosinophilic syndrome: A survey-based analysis
por: Espinoza, David F., et al.
Publicado: (2022)

Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Requena, Gema, et al.
Publicado: (2021)

Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
por: Just, Jocelyne, et al.
Publicado: (2020)

PB2229: NECESSITY FOR A ROBUST INFRASTRUCTURE FOR TREATING ALLIED COMPLICATIONS OF AGEING HAEMOGLOBINOPATHY POPULATION IN MIDDLE INCOME COUNTRIES
por: Imran, T., et al.
Publicado: (2022)

Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Fujii, Koki, et al.
Publicado: (2020)

Hypereosinophilic syndromes
por: Roufosse, Florence E, et al.
Publicado: (2007)

PB2253: HYPEREOSINOPHILIC SYNDROMES: CARDIAC EMERGENCY IN THE ELDERLY
por: Gougas, Ahlam, et al.
Publicado: (2023)

Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α – benralizumab
por: Kosałka-Węgiel, Joanna, et al.
Publicado: (2021)

Eosinophils and eosinophilic immune dysfunction in health and disease
por: Jackson, David J., et al.
Publicado: (2022)

Reply to Correspondence: Response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Fujii, Koki, et al.
Publicado: (2021)

Genomics of PDGFR-rearranged hypereosinophilic syndrome
por: Rheinbay, Esther, et al.
Publicado: (2023)

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
por: Roufosse, Florence, et al.
Publicado: (2020)

PReS-FINAL-2229: Pamidronate in CRMO - a small case series
por: Schuller, M, et al.
Publicado: (2013)

A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Report no. 8: Preliminary test on gate circuits cern NP-type 2229
por: Righini, B
Publicado: (1966)

Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023)

2229: Development of an angiogenic proteoglycan mimic to accelerate ischemic diabetic foot ulcer repair
por: Lin, Jenny, et al.
Publicado: (2018)

Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome
por: Nathan, Torcida, et al.
Publicado: (2023)

Report no. 10: Comparison test between gate circuits of the firm "X" and CERN NP-type 2229
por: Righini, B
Publicado: (1967)

2229. Impact of Elexacaftor/tezacaftor/ivacaftor on Utilization of Antibiotics at a Single Pediatric Cystic Fibrosis Center
por: Elson, Elizabeth C, et al.
Publicado: (2023)

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
por: Terrier, Benjamin, et al.
Publicado: (2023)

Transcript- and protein-level analyses of the response of human eosinophils to glucocorticoids
por: Gadkari, Manasi, et al.
Publicado: (2018)

Successful treatment of eosinophilic cystitis with benralizumab
por: Cooke, W Donald, et al.
Publicado: (2020)

Eosinophilic bronchiolitis successfully treated with benralizumab
por: Sugino, Keishi, et al.
Publicado: (2021)

Cardiac involvement in hypereosinophilic syndrome
por: Mansour, Mohamad Jihad, et al.
Publicado: (2018)

Eosinophilic myocarditis and hypereosinophilic syndrome
por: Boussir, Hanane, et al.
Publicado: (2017)

Hypereosinophilic Syndrome With Eosinophilic Gastritis
por: Nayak, Vignesh Hebri, et al.
Publicado: (2017)

Hypereosinophilic syndrome presenting as coagulopathy
por: Aukstuolis, Kestutis, et al.
Publicado: (2022)

Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia
por: Isomoto, Kohsuke, et al.
Publicado: (2020)

2229. Low Hepatitis C Virus Reinfection Rates After Sustained Viral Response in HIV Co-infected Patients in Houston, Texas
por: Offor, Lynda, et al.
Publicado: (2018)

Gastrointestinal and Hepatic Involvement in Hypereosinophilic Syndrome
por: Inayat, Faisal, et al.
Publicado: (2016)

Idiopathic hypereosinophilic syndrome with pulmonary hypertension
por: Zhang, Liping, et al.
Publicado: (2018)

Hypereosinophilic vasculitis: A case report
por: Alzayer, Husam, et al.
Publicado: (2019)

COVID-19 Pneumonia or Hypereosinophilic Syndrome?
por: Serin, Istemi, et al.
Publicado: (2020)

Literature reviews of stroke with hypereosinophilic syndrome
por: Ono, Ryohei, et al.
Publicado: (2021)

Crusted Scabies Induced Hypereosinophilic Syndrome
por: Shrestha, Asis, et al.
Publicado: (2021)

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023)

The dermatologic and histologic spectrum of hypereosinophilic syndrome
por: Long, Calista, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o1rj6mdppm6aka6pi6n7oc5akr